Throdahl Mark C 4
4 · ORTHOPEDIATRICS CORP · Filed Aug 4, 2021
Insider Transaction Report
Form 4
Throdahl Mark C
Director
Transactions
- Sale
Common Stock
[F1][F2]2021-08-03$65.40/sh−4,774$312,220→ 131,737 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Includes restricted stock awards totaling 29,572 shares.
Signature
/s/ Daniel J. Gerritzen, Attorney-in-Fact|2021-08-04